Ispecimen Inc (ISPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,099 | 27,739 | 9,791 | 13,184 | 0 |
| Receivables | 3,756 | 4,882 | 4,649 | 3,292 | 0 |
| TOTAL | $30,151 | $32,948 | $14,899 | $16,919 | $0 |
| Non-Current Assets | |||||
| PPE Net | 28 | 33 | 45 | 56 | N/A |
| Other Non-Current Assets | 3,108 | 2,738 | 2,679 | 2,631 | 0 |
| TOTAL | $3,136 | $2,771 | $2,723 | $2,686 | $N/A |
| Total Assets | $33,287 | $35,720 | $17,622 | $19,605 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 282 | 833 | 351 | 3,233 | 0 |
| Accrued Expenses | 1,048 | 1,018 | 1,033 | 1,890 | 0 |
| TOTAL | $2,047 | $2,505 | $2,103 | $5,926 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 567 | 655 | 719 | 803 | N/A |
| Other Non-Current Liabilities | 3,573 | 3,423 | 3,428 | 3,000 | 0 |
| TOTAL | $3,573 | $3,423 | $3,428 | $3,000 | $N/A |
| Total Liabilities | $5,620 | $5,928 | $5,531 | $8,926 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 441 | 441 | 350 | 346 | 325 |
| Common Shares | 1 | 1 | 1 | 1 | 0 |
| Retained earnings | -40,403 | -38,019 | -35,969 | -34,416 | 0 |
| TOTAL | $27,667 | $29,792 | $12,091 | $10,679 | $0 |
| Total Liabilities And Equity | $33,287 | $35,720 | $17,622 | $19,605 | $0 |